Search
01/06/2023
Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma"
Asero, V, Scornajenghi, CM, Krajewski, W, Szydelko, T, Malkiewicz, B, Nowak, L, Gallioli, A, Basran, S, Chung, BI, del Giudice, F. Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma". Minerva Urology And Nephrology. 2023; 75(3)DOI:10.23736/S2724-6051.23.05354-5. PMID:37221829. IF:4.900(Q1/2D).
01/06/2023
Comment on: "Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG"
Lonati, C, Soria, F, Pradere, B, D'Andrea, D, Laukhtina, E, Mertens, LS, Albisinni, S, Krajewski, W, Afferi, L, Del Giudice, F, Gallioli, A, Moschini, M, Urothelial Carcinoma Working Grp. Comment on: "Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG". Minerva Urology And Nephrology. 2023; 75(3)DOI:10.23736/S2724-6051.23.05337-5. PMID:37221831. IF:4.900(Q1/2D).
01/06/2023
Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.
Ruiz-Villaverde R, Galán-Gutiérrez M, Llamas-Velasco M, Salgado-Boquete L, Puig L, de la Cueva P, Carrascosa JM. Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.. Actas Dermo-Sifiliograficas. 2023; 114(6)DOI:10.1016/j.ad.2023.02.016. PMID:36906260. IF:(Q/D).
01/06/2023
Calibration of a three-state cell death model for cardiomyocytes and its application in radiofrequency ablation
Petras, A, Leoni, M, Guerra, JM, Gerardo-Giorda, L. Calibration of a three-state cell death model for cardiomyocytes and its application in radiofrequency ablation. PHYSIOLOGICAL MEASUREMENT. 2023; 44(6)DOI:10.1088/1361-6579/acdcdd. PMID:37290447. IF:2.300(Q3/6D).